Navigation Links
Bristol-Myers Squibb Board Elects James M. Cornelius Chairman of the Board
Date:2/12/2008

18 months as CEO, I have been deeply impressed by the commitment and dedication of our employees to our mission and goals, and the strong belief they share with me in the promise of Bristol-Myers Squibb as a BioPharma leader for the future. We're now embarking together on an exciting transformation aimed at making this company better able to deliver superior value to shareholders while also helping more people prevail over serious disease.

"I'm also honored to be succeeding Jim Robinson as chairman. Jim's long and distinguished tenure on our Board has been characterized by many successes and achievements. He came to the chairmanship during a challenging period in our company's recent past, moving quickly to restore confidence, build trust and inspire belief in the importance of our mission and the tremendous opportunities ahead. He has been a trusted advisor and a friend, and I'm grateful for the confidence he has shown in me and in our management team as we move forward."

Prior to coming to Bristol-Myers Squibb, Mr. Cornelius served as chairman emeritus of the Guidant Board of Directors upon closing of its merger into Boston Scientific in April 2006. Previously he had been chairman and CEO during the merger process and was responsible for the company's initial public offering and subsequent split-off from Eli Lilly and Company in 1995.

Mr. Cornelius was a member of the Board of Directors of Eli Lilly, a member of its Executive Committee and chief financial officer from 1983 to 1995. From 1980 to 1982, he served as president and CEO of IVAC Corporation, previously an Eli Lilly subsidiary. He was born in Kalamazoo, Michigan, and attended Michigan State University, where he earned a BA magna cum laude in accounting in 1965 and an MBA in 1967.

Bristol-Myers Squibb Company is a global biopharmaceutical and related health care products company whose mission is to extend and enhance human life.


'/>"/>
SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
2. Bristol-Myers Squibb to Acquire Adnexus Therapeutics
3. Aureus Pharma Announces Renewal and Expansion of Licensing Agreement With Bristol-Myers Squibb for its AurSCOPE Knowledge Databases
4. Bristol-Myers Squibb and Pierre Fabre Provide Update On Vinflunine Development Status
5. Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community
6. EDS Awarded $715 Million Contract for Bristol-Myers Squibb Information Services
7. Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb
8. Bristol-Myers Squibb to Announce Results for the Fourth Quarter and Full Year of 2007 on January 31
9. GeneGo Enters Multi-Year Agreement With Bristol Myers Squibb for Access to GeneGo Software Suite and Databases
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. KGI Elects Three New Members to Board of Trustees

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...s Customers with Partners Validated to Process and...ts , Ottawa, ON (PRWEB) N...der of products for biological sample collection, ... new global partner program. The program offers si...ommunity and is designed to help partners scale an...
(Date:11/23/2009)...ovocative new study, a University of Utah scientis... major cause of global warming cannot be stabiliz... builds the equivalent of one new nuclear power pl...ill be any substantial near-term departure from re...ssion rates," says the new paper by Tim Garrett, a...
(Date:11/23/2009)...carbon layer in which the carbon atoms are arrange...Carbon nanotubes are rolled-up sheets of graphene,... Graphene boasts some very special characteristics...rmal conductor, and reconciles such conflicting qu... graphene is impermeable to gases, which makes it ...
(Date:11/23/2009)...irstCall/--NeogenCorporation(Nasdaq: NEOG )announc...en,sBoardofDirectorsatthecompany,srecentannualmeet...ofexperienceinthefood,agriculture,andtradeindustri...uraleconomicsatVirginiaTechUniversity.FromJanuary2...turenegotiatorwiththerankofambassador. ,, "Sinc...
Breaking Biology Technology:DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4Polymer with honeycomb structure 2Richard T. Crowder Joins Neogen's Board of Directors 2
..., Oct. 24 SenesTech, Inc. has initiated,field tri...sland of Java in,continuing research collaboration... Dr. Grant Singleton of the International Rice,Res...ta Mayer and Cheryl,Dyer of SenesTech, Inc. will j...cientific and Industrial Research Organisation (CS...
...t. 24 The Committee for,Medicinal Products for Hu...MEA) has adopted a negative opinion on a Cymbalta(...treatment of fibromyalgia., "Eli Lilly and Compan...ted by the CHMP,s opinion," said James Russell, M....lly and Company. "We remain,confident in the dulox...
...24 Favrille, Inc. (OTC,Bulletin Board: FVRL) anno... term sheet for a reverse merger whereby Favrille ...e company, MyMedicalRecords.com, Inc.,("MMR"), in ...becoming a,wholly-owned subsidiary of Favrille. If...rms set forth in the non-binding term sheet, at th...
Other Biology Technology:SenesTech, Inc. Initiates Research Field Trials for ContraPest(R) in Indonesia 2European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia 2European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia 3European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia 4European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia 5Favrille Announces Execution of Non-binding Term Sheet for a Merger Transaction 2
(Date:11/23/2009)...ire microbiologist Louis Tisa has received two gra...the actinorhizal plants, widespread woody plants w...ated soils. , The United States Department of A...ecular, cellular and biomedical sciences, $399,000... bacteria Frankia and Casuarina, an actinorhizal p...
(Date:11/23/2009)...edical engineer and cardiologist Tzung "John" Hsia...istinguish cardiac emergencies requiring immediate...gs and lifestyle change. , Angiograms, images ma... the heart, offer an inside view of the interior s...ealing deposits of a dangerous fatty substance cal...
(Date:11/23/2009)...sted for 360 million years and survived when the d...tening to make many of them extinct, according to ...Today . , The fungus, Batrachochytrium dendrob...s of amphibian extinctions in Central America and ...over 350 amphibian species by penetrating their sk...
Breaking Biology News(10 mins):UNH prof. receives nearly $500,000 to research environmentally significant plants 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Keryx Reports Results of Open Label Extension Study Examining Long Term Use of Zerenex an Iron Based Phosphate Binder for the Treatment of Hyperphos 5032 1Keryx Reports Results of Open Label Extension Study Examining Long Term Use of Zerenex an Iron Based Phosphate Binder for the Treatment of Hyperphos 5032 2Keryx Reports Results of Open Label Extension Study Examining Long Term Use of Zerenex an Iron Based Phosphate Binder for the Treatment of Hyperphos 5032 3Keryx Reports Results of Open Label Extension Study Examining Long Term Use of Zerenex an Iron Based Phosphate Binder for the Treatment of Hyperphos 5032 4Discovery could improve hepatitis C treatment 58129 1Discovery could improve hepatitis C treatment 58129 2InVitria Presents Zap CHO Performance Results at PEACe Conference 10054 1InVitria Presents Zap CHO Performance Results at PEACe Conference 10054 2
..., A collaboration between more than 70 researcher... the X chromosome that, when knocked-out, lead to ...ied almost all X chromosome genes in 208 families ... this type ever reported. , Remarkably, the team...omosome genes, when knocked-out, have no apparent ...
..., SALT LAKE CITY As the U.S. Southwest grew war... vanished from what is now the Mojave Desert, robb...ty of Utah biologists have narrowed the hunt for d... creosote bushes that replaced juniper. , "It wa...or Denise Dearing, senior author of the study, pub...
..., , As the U.S. Southwest grew warmer between 18,7...om what is now the Mojave Desert, robbing woodrats...rrowed the hunt for detoxification genes that let ...laced junipers. , "It was either eat it or move o...ty of Utah, lead author of a paper detailing the r...
Other Biology News:The genetic X-factor 2The genetic X-factor 3Poison: It's what's for dinner 2Poison: It's what's for dinner 3Poison: It's what's for dinner 4Poison: It's what's for dinner 5Desert woodrats switch one dietary poison for another 2
...y scanner based on patented confocal laser imaging...patial resolution. The DNAscope LM is unique beca...t is upgradeable to a total of 3 laser excitation ... (computer), monitor, and software easy to use ...
...ures an ultra-thin nitrocellulose coating for mult...rst protein microarray slide to provide the many b...background fluorescence providing excellent signal...ed for a variety of assays, such as sandwich immun...
Conjugate Stabilizing Diluent Alkaline Phosphatase from Meridian Life Science, Inc.
...Alkaline Phosphatase conjugates. The product insu...the enzyme and the antibody following long-term st...emically engineered to increase conjugate stabilit...stance to various shipping conditions and storage ...
Biology Products: